Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy. Issue 2 (1st December 2022)
- Record Type:
- Journal Article
- Title:
- Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy. Issue 2 (1st December 2022)
- Main Title:
- Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy
- Authors:
- Rodbard, David
- Abstract:
- Abstract: Aim: To evaluate continuous glucose monitoring (CGM) metrics for use as alternatives to glycated haemoglobin (HbA1c ) to evaluate therapeutic efficacy. Methods: We re‐analysed correlations among CGM metrics from studies involving 545 people with type 1 diabetes (T1D), 5910 people with type 2 diabetes (T2D) and 98 people with T1D during pregnancy and the postpartum period. Results: Three CGM metrics, interstitial fluid Mean Glucose level, proportion of time above range ( %TAR ) and proportion of time in range ( %TIR ), were correlated with HbA1c and provided metrics that can be used to evaluate therapeutic efficacy. Mean Glucose showed the highest correlation with %TAR ( r = 0.98 in T1D, 0.97 in T2D) but weaker correlations with %TIR ( r = −0.92 in T1D, −0.83 in T2D) or with HbA1c ( r = 0.78 in T1D). %TAR and %TIR were highly correlated ( r = −0.96 in T1D, −0.91 in T2D). After 6 months of use of real‐time CGM by people with T1D, changes in Mean Glucose level were more highly correlated with changes in %TAR ( r = 0.95) than with changes in %TIR ( r = −0.85) or with changes in HbA1c level ( r = 0.52). These metrics can be combined with metrics of hypoglycaemia and/or glycaemic variability to provide a more comprehensive assessment of overall quality of glycaemic control. Conclusion: The CGM metrics %TAR and %TIR show much higher correlations with Mean Glucose than with HbA1c and provide sensitive indicators of efficacy. Mean glucose may be the best metric andAbstract: Aim: To evaluate continuous glucose monitoring (CGM) metrics for use as alternatives to glycated haemoglobin (HbA1c ) to evaluate therapeutic efficacy. Methods: We re‐analysed correlations among CGM metrics from studies involving 545 people with type 1 diabetes (T1D), 5910 people with type 2 diabetes (T2D) and 98 people with T1D during pregnancy and the postpartum period. Results: Three CGM metrics, interstitial fluid Mean Glucose level, proportion of time above range ( %TAR ) and proportion of time in range ( %TIR ), were correlated with HbA1c and provided metrics that can be used to evaluate therapeutic efficacy. Mean Glucose showed the highest correlation with %TAR ( r = 0.98 in T1D, 0.97 in T2D) but weaker correlations with %TIR ( r = −0.92 in T1D, −0.83 in T2D) or with HbA1c ( r = 0.78 in T1D). %TAR and %TIR were highly correlated ( r = −0.96 in T1D, −0.91 in T2D). After 6 months of use of real‐time CGM by people with T1D, changes in Mean Glucose level were more highly correlated with changes in %TAR ( r = 0.95) than with changes in %TIR ( r = −0.85) or with changes in HbA1c level ( r = 0.52). These metrics can be combined with metrics of hypoglycaemia and/or glycaemic variability to provide a more comprehensive assessment of overall quality of glycaemic control. Conclusion: The CGM metrics %TAR and %TIR show much higher correlations with Mean Glucose than with HbA1c and provide sensitive indicators of efficacy. Mean glucose may be the best metric and shows consistently higher correlations with %TAR than with %TIR . … (more)
- Is Part Of:
- Diabetes, obesity & metabolism. Volume 25:Issue 2(2023)
- Journal:
- Diabetes, obesity & metabolism
- Issue:
- Volume 25:Issue 2(2023)
- Issue Display:
- Volume 25, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 25
- Issue:
- 2
- Issue Sort Value:
- 2023-0025-0002-0000
- Page Start:
- 596
- Page End:
- 601
- Publication Date:
- 2022-12-01
- Subjects:
- Mean Glucose -- %TAR -- %TIR -- HbA1c -- efficacy -- quality of glycemic control -- type 1 diabetes (T1D) -- type 2 diabetes (T2D) -- glycemic variability
Diabetes -- Periodicals
Obesity -- Periodicals
Metabolism -- Disorders -- Periodicals
Clinical pharmacology -- Periodicals
616.462 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=1462-8902&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1463-1326 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/dom.14906 ↗
- Languages:
- English
- ISSNs:
- 1462-8902
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.601970
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25191.xml